This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adrian, P. V.
Right arrow Articles by Klugman, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adrian, P. V.
Right arrow Articles by Klugman, K. P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2000, p. 732-738, Vol. 44, No. 3
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Mutations in Ribosomal Protein L16 Conferring Reduced Susceptibility to Evernimicin (SCH27899): Implications for Mechanism of Action

Peter V. Adrian,1,* Wenjun Zhao,2 Todd A. Black,2 Karen J. Shaw,2 Roberta S. Hare,2 and Keith P. Klugman1

Pneumococcal Diseases Research Unit of the South African Institute for Medical Research, University of the Witwatersrand and the Medical Research Council, Johannesburg, South Africa,1 and Schering Plough Research Institute, Kenilworth, New Jersey2

Received 8 July 1999/Returned for modification 8 October 1999/Accepted 16 December 1999

A clinical isolate of Streptococcus pneumoniae (SP#5) that showed decreased susceptibility to evernimicin (MIC, 1.5 µg/ml) was investigated. A 4,255-bp EcoRI fragment cloned from SP#5 was identified by its ability to transform evernimicin-susceptible S. pneumoniae R6 (MIC, 0.03 µg/ml) such that the evernimicin MIC was 1.5 µg/ml. Nucleotide sequence analysis of this fragment revealed that it contained portions of the S10-spc ribosomal protein operons. The nucleotide sequences of resistant and susceptible isolates were compared, and a point mutation (thymine to guanine) that causes an Ile52-Ser substitution in ribosomal protein L16 was identified. The role of this mutation in decreasing susceptibility to evernimicin was confirmed by direct transformation of the altered L16 gene. The presence of the L16 mutation in the resistant strain suggests that evernimicin is an inhibitor of protein synthesis. This was confirmed by inhibition studies using radiolabeled substrates, which showed that the addition of evernimicin at sub-MIC levels resulted in a rapid decrease in the incorporation of radiolabeled isoleucine in a susceptible isolate (SP#3) but was much less effective against SP#5. The incorporation of isoleucine showed a linear response to the dose level of evernimicin. The incorporation of other classes of labeled substrates was unaffected or much delayed, indicating that these were secondary effects.

* Corresponding author. Present address: Department of Pediatrics, Postbus 1738, EE1502, 3000 DR, Rotterdam, The Netherlands. Phone: 31 10 4087998. Fax: 31 10 4089486. E-mail: adrian{at}kgk.fgg.eur.nl.

Antimicrobial Agents and Chemotherapy, March 2000, p. 732-738, Vol. 44, No. 3
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Lerner, C. G., Kakavas, S. J., Wagner, C., Chang, R. T., Merta, P. J., Ruan, X., Metzger, R. E., Beutel, B. A. (2005). Novel Approach to Mapping of Resistance Mutations in Whole Genomes by Using Restriction Enzyme Modulation of Transformation Efficiency. Antimicrob. Agents Chemother. 49: 2767-2777 [Abstract] [Full Text]  
  • Butaye, P., Devriese, L. A., Haesebrouck, F. (2003). Antimicrobial Growth Promoters Used in Animal Feed: Effects of Less Well Known Antibiotics on Gram-Positive Bacteria. Clin. Microbiol. Rev. 16: 175-188 [Abstract] [Full Text]  
  • Kofoed, C. B., Vester, B. (2002). Interaction of Avilamycin with Ribosomes and Resistance Caused by Mutations in 23S rRNA. Antimicrob. Agents Chemother. 46: 3339-3342 [Abstract] [Full Text]  
  • Zarazaga, M., Tenorio, C., Del Campo, R., Ruiz-Larrea, F., Torres, C. (2002). Mutations in Ribosomal Protein L16 and in 23S rRNA in Enterococcus Strains for Which Evernimicin MICs Differ. Antimicrob. Agents Chemother. 46: 3657-3659 [Abstract] [Full Text]  
  • Smith, A. M., Klugman, K. P. (2001). Alterations in MurM, a Cell Wall Muropeptide Branching Enzyme, Increase High-Level Penicillin and Cephalosporin Resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45: 2393-2396 [Abstract] [Full Text]  
  • Butaye, P., Devriese, L. A., Haesebrouck, F. (2001). Differences in Antibiotic Resistance Patterns of Enterococcus faecalis and Enterococcus faecium Strains Isolated from Farm and Pet Animals. Antimicrob. Agents Chemother. 45: 1374-1378 [Abstract] [Full Text]  
  • Belova, L., Tenson, T., Xiong, L., McNicholas, P. M., Mankin, A. S. (2001). A novel site of antibiotic action in the ribosome: Interaction of evernimicin with the large ribosomal subunit. Proc. Natl. Acad. Sci. USA 10.1073/pnas.071527498v1 [Abstract] [Full Text]  
  • Weitnauer, G., Gaisser, S., Trefzer, A., Stockert, S., Westrich, L., Quiros, L. M., Mendez, C., Salas, J. A., Bechthold, A. (2001). An ATP-Binding Cassette Transporter and Two rRNA Methyltransferases Are Involved in Resistance to Avilamycin in the Producer Organism Streptomyces viridochromogenes Tu57. Antimicrob. Agents Chemother. 45: 690-695 [Abstract] [Full Text]  
  • McNicholas, P. M., Mann, P. A., Najarian, D. J., Miesel, L., Hare, R. S., Black, T. A. (2001). Effects of Mutations in Ribosomal Protein L16 on Susceptibility and Accumulation of Evernimicin. Antimicrob. Agents Chemother. 45: 79-83 [Abstract] [Full Text]  
  • Adrian, P. V., Mendrick, C., Loebenberg, D., McNicholas, P., Shaw, K. J., Klugman, K. P., Hare, R. S., Black, T. A. (2000). Evernimicin (SCH27899) Inhibits a Novel Ribosome Target Site: Analysis of 23S Ribosomal DNA Mutants. Antimicrob. Agents Chemother. 44: 3101-3106 [Abstract] [Full Text]  
  • Tait-Kamradt, A., Davies, T., Cronan, M., Jacobs, M. R., Appelbaum, P. C., Sutcliffe, J. (2000). Mutations in 23S rRNA and Ribosomal Protein L4 Account for Resistance in Pneumococcal Strains Selected In Vitro by Macrolide Passage. Antimicrob. Agents Chemother. 44: 2118-2125 [Abstract] [Full Text]  
  • McNicholas, P. M., Najarian, D. J., Mann, P. A., Hesk, D., Hare, R. S., Shaw, K. J., Black, T. A. (2000). Evernimicin Binds Exclusively to the 50S Ribosomal Subunit and Inhibits Translation in Cell-Free Systems Derived from both Gram-Positive and Gram-Negative Bacteria. Antimicrob. Agents Chemother. 44: 1121-1126 [Abstract] [Full Text]  
  • Belova, L., Tenson, T., Xiong, L., McNicholas, P. M., Mankin, A. S. (2001). A novel site of antibiotic action in the ribosome: Interaction of evernimicin with the large ribosomal subunit. Proc. Natl. Acad. Sci. USA 98: 3726-3731 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»